Thus, short-term therapeutic inhibition of the nucleocytoplasmic transport gene, Xpo1, induces tumor regression without affecting normal adjacent liver in an autochthonous transgenic mouse model of MYC-induced HCC. The gene discussed is MYC; the disease is hepatocellular carcinoma.